The growing challenge in cancer therapy lies in overcoming tumor heterogeneity, drug resistance, and associated side effects.
PPARs and PROTACs: A new strategy in cancer therapeutics
- Post author:
- Post published:September 13, 2024
- Post category:uncategorized